- Investing Ideas
- /
- Taiwanese Pharmaceuticals & Biotech Sustainable Track Record
Taiwanese Pharmaceuticals & Biotech Sustainable Track Record
Results
4
Companies which have reinvested earnings to sustain 10% yearly growth over 5 years.
4 companies
PharmaEngine
Market Cap: NT$9.7b
A biopharmaceutical company, engages in the development of drugs and therapeutic drugs for treating cancer in Taiwan.
4162
NT$67.20
7D
-0.1%
1Y
-23.3%
TTY Biopharm
Market Cap: NT$19.1b
Engages in the development and sale of pharmaceutical and chemical drugs in Taiwan and internationally.
4105
NT$76.80
7D
0.5%
1Y
2.1%
Lotus Pharmaceutical
Market Cap: NT$50.9b
Engages in the research and development, manufacture, and sale of generic pharmaceutical products in Taiwan, South Korea, the United States, and internationally.
1795
NT$193.50
7D
-0.3%
1Y
-32.6%
Bora Pharmaceuticals
Market Cap: NT$90.2b
Engages in contract development, manufacture, and sale of pharmaceuticals in Europe, the United States, Taiwan, and internationally.
6472
NT$727.00
7D
-2.5%
1Y
16.6%